NCT07332507 2026-03-18Testing the Effect of Teclistamab on Recurrent Plasmablastic LymphomaNational Cancer Institute (NCI)Phase 1 Not yet recruiting30 enrolled
NCT05389423 2026-02-19Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting25 enrolled